RedHill Biopharma (RDHL) EBT Margin (QoQ) (2012 - 2023)
RedHill Biopharma (RDHL) EBT Margin (QoQ) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 350,071.00 |
| Mar 31, 2023 | 32,318.00 |
| Dec 31, 2022 | -42,081.00 |
| Sep 30, 2022 | -15,842.00 |
| Jun 30, 2022 | -6,113.00 |
| Mar 31, 2022 | 74,143.00 |
| Dec 31, 2021 | -70,634.00 |
| Sep 30, 2021 | -3,399.00 |
| Jun 30, 2021 | 3,072.00 |
| Mar 31, 2021 | 1,623.00 |
| Dec 31, 2020 | 0.00 |
| Sep 30, 2020 | 626.00 |
| Jun 30, 2020 | -151,464.00 |
| Mar 31, 2020 | 81,302.00 |
| Dec 31, 2019 | 1,499.00 |
| Sep 30, 2019 | -17,423.00 |
| Jun 30, 2019 | 41,114.00 |
| Mar 31, 2019 | -42,001.00 |
| Dec 31, 2018 | 48,697.00 |
| Sep 30, 2018 | 8,536.00 |